DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile

When do Dextrose 5% And Sodium Chloride 0.9% In Plastic Container patents expire, and when can generic versions of Dextrose 5% And Sodium Chloride 0.9% In Plastic Container launch?

Dextrose 5% And Sodium Chloride 0.9% In Plastic Container is a drug marketed by Abbott, B Braun, Miles, and Otsuka Icu Medcl. and is included in five NDAs.

The generic ingredient in DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is dextrose; sodium chloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.

Summary for DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

US Patents:	0
Applicants:	4
NDAs:	5
Finished Product Suppliers / Packagers:	2
DailyMed Link:	DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed

Pharmacology for DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Drug Class	Osmotic Laxative
Mechanism of Action	Osmotic Activity
Physiological Effect	Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption

US Patents and Regulatory Information for DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	019483-001	Oct 4, 1985		DISCN	No	No
Miles	DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	018500-001	Approved Prior to Jan 1, 1982		DISCN	No	No
B Braun	DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	018026-001	Approved Prior to Jan 1, 1982		DISCN	No	No
B Braun	DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	019631-010	Feb 24, 1988	AP	RX	No	No

DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Market Analysis and Financial Projection

Last updated: February 12, 2026

Market Dynamics and Financial Trajectory for Dextrose 5% and Sodium Chloride 0.9% in Plastic Containers

Market Size and Growth Drivers

The intravenous (IV) fluids market, which includes Dextrose 5% and Sodium Chloride 0.9%, has seen consistent growth. The global market was valued at approximately $9.2 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4.8% during 2023-2030, driven by increasing healthcare spending, rising prevalence of dehydration and electrolyte imbalances, and expanding hospital infrastructure.

Market Segmentation and Volume

Product Segment:

• Dextrose 5% in plastic containers accounts for roughly 55% of the IV fluids market.
• Sodium Chloride 0.9% constitutes about 35%.
• Other solutions (e.g., Ringer’s lactate) comprise the remaining 10%.

Application Segment:

• Hospital use constitutes 75%.
• Emergency care accounts for 20%.
• Home healthcare and outpatient clinics make up 5%.

Plastic Container Format:
Polypropylene and polyethylene bottles dominate, favored for their durability, compatibility with sterilization processes, and cost-effectiveness. The shift from glass to plastic containers has been driven by safety, weight, and transport considerations.

Key Players and Market Composition

Major manufacturers include Baxter International, B. Braun Melsungen, Hospira (a Pfizer company), and Fresenius Kabi. Competition is driven by pricing, supply reliability, and compliance with regulatory standards.

Pricing Trends and Revenue Forecast

Pricing:

• The average cost per unit for Dextrose 5% in a 500 mL plastic bag is approximately $1.50 to $2.00.
• Sodium Chloride 0.9% in similar volumes ranges from $1.20 to $1.80.

Revenue Trajectory:
Major companies report revenues between $150 million and $300 million annually from these solutions, with margins historically around 20-25%. As demand stabilizes, revenue increases are closely tied to volume growth rather than price inflation.

Regulatory Environment and Impact

Regulatory authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce compliance with Good Manufacturing Practices (GMP). Changes in regulations or shortages in raw materials can cause supply chain disruptions, affecting pricing and availability.

Market Risks and Challenges

• Supply Chain Disruptions: Raw material shortages (e.g., glucose monohydrate, sodium chloride) impact production.
• Competitive Pricing: Price competition among established players compresses margins.
• Regulatory Changes: Stricter sterilization and safety guidelines could increase compliance costs.
• Market Saturation: Growth slows in mature markets with high penetration.

Emerging Trends and Opportunities

• Sterility and Safety Innovations: Use of advanced sterilization and container seal technologies.
• Expanded Use Cases: Applications in outpatient settings, home care, and specialized clinics.
• Regional Expansion: Increasing access in emerging markets, especially in Asia-Pacific and Latin America.

Financial Outlook

Projection indicates steady revenue growth through 2030, with a focus on volume expansion rather than price increases. Companies investing in supply chain resilience and regulatory compliance are positioned to maintain margins and market share. Cost management, especially in raw materials and manufacturing efficiencies, will influence profitability.

Key Takeaways

• Market size for Dextrose 5% and Sodium Chloride 0.9% in plastic containers is around $3.2 billion worldwide (2022).
• CAGR of approximately 4.8% expected through 2030.
• Leading producers include Baxter, B. Braun, Hospira, and Fresenius Kabi.
• Market growth driven by healthcare infrastructure expansion, aging populations, and increased clinical use.
• Price pressure exists, with margins impacted by raw material costs and regulatory compliance.
• Opportunities involve innovations in container safety and expansion into emerging markets.

FAQs

1. What factors influence the pricing of IV solutions in plastic containers?
Raw material costs, manufacturing efficiency, regulatory compliance, and market competition affect pricing. Supply chain disruptions and raw material shortages can increase costs.

2. How does regulatory environment impact the market?
Regulations require compliance with sterilization standards and manufacturing practices. Changes can increase capital and operational expenses, affecting supply and pricing.

3. What are the main growth regions for these IV solutions?
The U.S., Europe, and emerging markets like China and India. Asia-Pacific exhibits high growth potential due to expanding healthcare infrastructure.

4. Are there significant patent protections for these solutions?
Standard formulations like Dextrose 5% and Sodium Chloride 0.9% are typically off-patent, relying on manufacturing, branding, and regulatory approvals for competitive advantage.

5. What technological trends are influencing future market development?
Advances in container sterilization, safety seals, and infusion pump compatibility. Innovations aim to improve safety, stability, and logistical efficiency.

---

Sources:

1. MarketsandMarkets. (2022). Intravenous (IV) fluids market data.
2. Transparency Market Research. (2022). IV solutions industry overview.
3. U.S. FDA. (2022). Regulatory guidelines for sterile medical solutions.
4. International Data Corporation. (2022). Healthcare devices and supplies market trends.
5. Company annual reports and industry filings (2022).